We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining
Cancer Chemother Pharmacol 2011, PMID: 21120482

Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.

Yu, Wei; Chen, Li; Yang, Yu-Qing; Falck, John R; Guo, Austin M; Li, Ying; Yang, Jing

OBJECTIVE

Cytochrome P450 (CYP) ω-hydroxylase, mainly consisting of CYP4A and CYP4F, converts arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE) that induces angiogenic responses in vivo and in vitro. The present study examined the role of CYP ω-hydroxylase in angiogenesis and metastasis of human non-small cell lung cancer (NSCLC).

METHODS

The effect of WIT003, a stable 20-HETE analog, on invasion was evaluated using a modified Boyden chamber in three NSCLC cell lines. A549 cells were transfected with CYP4A11 expression vector or exposed to CYP ω-hydroxylase inhibitor (HET0016) or 20-HETE antagonist (WIT002), and then ω-hydroxylation activity toward arachidonic acid and the levels of matrix metalloproteinases (MMPs) and VEGF were detected. The in vivo effects of CYP ω-hydroxylase were tested in established tumor xenografts and an experimental metastasis model in athymic mice.

RESULTS

Addition of WIT003 or overexpression of CYP4A11 with an associated increase in 20-HETE production significantly induced invasion and expression of VEGF and MMP-9. Treatment of A549 cells with HET0016 or WIT002 inhibited invasion with reduction in VEGF and MMP-9. The PI3 K or ERK inhibitors also attenuated expression of VEGF and MMP-9. Compared with control, CYP4A11 transfection significantly increased tumor weight, microvessel density (MVD), and lung metastasis by 2.5-fold, 2-fold, and 3-fold, respectively. In contrast, WIT002 or HET0016 decreased tumor volume, MVD, and spontaneous pulmonary metastasis occurrences.

CONCLUSIONS

CYP ω-hydroxylase promotes tumor angiogenesis and metastasis by upregulation of VEGF and MMP-9 via PI3 K and ERK1/2 signaling in human NSCLC cells.

Diseases/Pathways annotated by Medline MESH: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neovascularization, Pathologic
Document information provided by NCBI PubMed

Text Mining Data

VEGF → ERK: " The PI3 K or ERK inhibitors also attenuated expression of VEGF and MMP-9 "

VEGF → PI3 K: " The PI3 K or ERK inhibitors also attenuated expression of VEGF and MMP-9 "

MMP-9 → ERK: " The PI3 K or ERK inhibitors also attenuated expression of VEGF and MMP-9 "

MMP-9 → PI3 K: " The PI3 K or ERK inhibitors also attenuated expression of VEGF and MMP-9 "

Manually curated Databases

No curated data.